USANA Health Sciences Inc (USNA)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 744,317 747,083 762,987 783,068 804,711 837,962 874,859 939,725 968,566 1,005,286 1,023,804 955,298 925,533 898,041 868,665 866,870 873,399 898,946 931,057 973,004
Revenue (ttm) US$ in thousands 923,232 929,999 950,124 976,483 1,001,860 1,041,382 1,082,496 1,155,009 1,190,168 1,235,586 1,258,823 1,180,028 1,137,751 1,095,421 1,057,506 1,054,531 1,060,902 1,088,627 1,124,796 1,170,240
Gross profit margin 80.62% 80.33% 80.30% 80.19% 80.32% 80.47% 80.82% 81.36% 81.38% 81.36% 81.33% 80.96% 81.35% 81.98% 82.14% 82.20% 82.33% 82.58% 82.78% 83.15%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $744,317K ÷ $923,232K
= 80.62%

USANA Health Sciences Inc has demonstrated a relatively stable gross profit margin over the past few quarters, hovering around the range of 80% to 82%. The company's gross profit margin peaked at 83.15% in the first quarter of 2019 and has since experienced a slight decline, with the latest reported margin at 80.62% as of December 31, 2023.

Overall, the company has maintained healthy levels of gross profit margin, indicating efficient cost management and effective pricing strategies. It is essential for USANA Health Sciences Inc to continue monitoring and optimizing its cost structure to sustain its profitability and competitive positioning in the market.